Tapewire

Nasdaq · USD

BCYC

BICYCLE THERAPEUTICS PLC

Export transactions ↓
Tapewire entity
5993
SEC CIK
0001761612
Parsed reports
304

Last 12 months

Inside the activity.

0 purchase rows · 49 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 2026013
Feb 202600
Mar 202600
Apr 2026011
May 202600
Jun 202600
Jul 2026011
Aug 202600
Sep 202600
Oct 2026014

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2026 Filed Jan 6, 2026 22:41 UTC
BAKER BROS. ADVISORS LPDirector · 10% owner
667, L.P.Director · 10% owner
Baker Bros. Advisors (GP) LLCDirector · 10% owner
Baker Brothers Life Sciences LPDirector · 10% owner
BAKER FELIXDirector · 10% owner
BAKER JULIANDirector · 10% owner
GrantAmerican Depositary Shares 19,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-004828 · ownership.xml · nonDerivative · entry 2

BAKER BROS. ADVISORS LP · CIK 0001263508 · Director · 10% owner

667, L.P. · CIK 0001551139 · Director · 10% owner

Baker Bros. Advisors (GP) LLC · CIK 0001580575 · Director · 10% owner

Baker Brothers Life Sciences LP · CIK 0001363364 · Director · 10% owner

BAKER FELIX · CIK 0001087940 · Director · 10% owner

BAKER JULIAN · CIK 0001087939 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 10,018,674

F1 · shares: Includes 19,000 restricted share units (each an "RSU") payable in American Depositary Shares ("ADS") or Ordinary Shares ("Ordinary Shares") at the option of Bicycle Therapeutics plc (the "Issuer") granted by the Issuer to Felix J. Baker, a managing member of Baker Bros. Advisors (GP) LLC (the "Adviser GP") on January 2, 2026 pursuant to the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The RSUs vest in four equal quarterly installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026, subject to Felix J. Baker's continuous service on the board of directors of the Issuer (the "Board") through such vesting dates. Felix J. Baker serves on the Board as a representative of 667, L.P. ("667") and Baker Brothers Life Sciences, L.P. ("Life Sciences", and together with 667, the "Funds"). Each RSU represents a contingent right to receive one ADS or Ordinary Share.

F2 · ownership.nature: ADS each represent 1 Ordinary Share.

F4 · ownership.nature: Baker Bros. Advisors LP ("the Adviser") serves as the investment adviser to the Funds. In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held directly by or held for the benefit of the Funds. The Adviser GP is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are managing members of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held directly by or held for the benefit of the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held directly by or held for the benefit of the Funds.

F5 · ownership.nature: Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by or held for the benefit of the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose.

F6 · ownership.nature: Includes beneficial ownership of 16,400 ADS issuable upon the vesting of RSUs payable in ADS or Ordinary Shares at the Issuer's option previously issued to Felix J. Baker, in his capacity as a director of the Issuer pursuant to the 2020 Plan of which the Funds may be deemed to own a portion. 8,400 of the RSUs previously granted are fully vested and the remaining 8,000 vest in two equal annual installments beginning on April 18, 2026, subject to Felix J. Baker's continuous service on the Board through the vesting date. Felix J. Baker serves on the Board as a representative of the Funds and their affiliates and control persons. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer.

F7 · ownership.nature: Pursuant to the policies of the Adviser, Felix J. Baker does not have any right to any of the Issuer's securities issued as compensation for his service on the Board and the Funds are entitled to an indirect proportionate pecuniary interest in the securities. The Funds each own an indirect proportionate pecuniary interest in the ADS or Ordinary Shares received upon vesting of RSUs and non-qualified share options exercisable into ADS or Ordinary Shares of the Issuer ("Share Options") received as a result of his service on the Board. Solely as a result of their ownership interest in (i) the general partners of the Funds and (ii) the Funds, Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest in the ADS or Ordinary Shares received upon vesting of RSUs, Share Options, and ADS or Ordinary Shares received upon the exercise of Share Options (i.e. no direct pecuniary interest) issued as compensation for such Board service.

F8 · ownership.nature: The Adviser has voting and dispositive power over the Share Options, RSUs and any ADS or Ordinary Shares received as a result of the exercise of Share Options or vesting of RSUs.

F9 · ownership.nature: After giving effect to the transaction reported herein and as a result of their ownership interest in (i) Baker Brothers Life Sciences Capital, L.P. and (ii) Life Sciences, Julian C. Baker and Felix J. Baker may be deemed to have an indirect pecuniary interest in the securities reported in column 5 of Table I and in column 9 of Table II directly held by or held for the benefit of Life Sciences, a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital, L.P., a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital (GP), LLC, due to their interest in Life Sciences and Baker Brothers Life Sciences Capital, L.P.'s right to receive an allocation of a portion of the profits from Life Sciences.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:41 UTC
BAKER BROS. ADVISORS LPDirector · 10% owner
667, L.P.Director · 10% owner
Baker Bros. Advisors (GP) LLCDirector · 10% owner
Baker Brothers Life Sciences LPDirector · 10% owner
BAKER FELIXDirector · 10% owner
BAKER JULIANDirector · 10% owner
GrantAmerican Depositary Shares 19,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-004828 · ownership.xml · nonDerivative · entry 1

BAKER BROS. ADVISORS LP · CIK 0001263508 · Director · 10% owner

667, L.P. · CIK 0001551139 · Director · 10% owner

Baker Bros. Advisors (GP) LLC · CIK 0001580575 · Director · 10% owner

Baker Brothers Life Sciences LP · CIK 0001363364 · Director · 10% owner

BAKER FELIX · CIK 0001087940 · Director · 10% owner

BAKER JULIAN · CIK 0001087939 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 937,483

F1 · shares: Includes 19,000 restricted share units (each an "RSU") payable in American Depositary Shares ("ADS") or Ordinary Shares ("Ordinary Shares") at the option of Bicycle Therapeutics plc (the "Issuer") granted by the Issuer to Felix J. Baker, a managing member of Baker Bros. Advisors (GP) LLC (the "Adviser GP") on January 2, 2026 pursuant to the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The RSUs vest in four equal quarterly installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026, subject to Felix J. Baker's continuous service on the board of directors of the Issuer (the "Board") through such vesting dates. Felix J. Baker serves on the Board as a representative of 667, L.P. ("667") and Baker Brothers Life Sciences, L.P. ("Life Sciences", and together with 667, the "Funds"). Each RSU represents a contingent right to receive one ADS or Ordinary Share.

F2 · ownership.nature: ADS each represent 1 Ordinary Share.

F3 · ownership.nature: After giving effect to the transactions reported herein and as a result of their ownership interest in (i) Baker Biotech Capital, L.P. and (ii) 667, Julian C. Baker and Felix J. Baker each may be deemed to have an indirect pecuniary interest in the securities reported in column 5 of Table I and in column 9 of Table II directly held by or held for the benefit of 667, a limited partnership of which the sole general partner is Baker Biotech Capital, L.P., a limited partnership of which the sole general partner is Baker Biotech Capital (GP), LLC, due to their interest in 667 and Baker Biotech Capital, L.P.'s right to receive an allocation of a portion of the profits from 667.

F4 · ownership.nature: Baker Bros. Advisors LP ("the Adviser") serves as the investment adviser to the Funds. In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held directly by or held for the benefit of the Funds. The Adviser GP is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are managing members of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held directly by or held for the benefit of the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held directly by or held for the benefit of the Funds.

F5 · ownership.nature: Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by or held for the benefit of the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose.

F6 · ownership.nature: Includes beneficial ownership of 16,400 ADS issuable upon the vesting of RSUs payable in ADS or Ordinary Shares at the Issuer's option previously issued to Felix J. Baker, in his capacity as a director of the Issuer pursuant to the 2020 Plan of which the Funds may be deemed to own a portion. 8,400 of the RSUs previously granted are fully vested and the remaining 8,000 vest in two equal annual installments beginning on April 18, 2026, subject to Felix J. Baker's continuous service on the Board through the vesting date. Felix J. Baker serves on the Board as a representative of the Funds and their affiliates and control persons. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer.

F7 · ownership.nature: Pursuant to the policies of the Adviser, Felix J. Baker does not have any right to any of the Issuer's securities issued as compensation for his service on the Board and the Funds are entitled to an indirect proportionate pecuniary interest in the securities. The Funds each own an indirect proportionate pecuniary interest in the ADS or Ordinary Shares received upon vesting of RSUs and non-qualified share options exercisable into ADS or Ordinary Shares of the Issuer ("Share Options") received as a result of his service on the Board. Solely as a result of their ownership interest in (i) the general partners of the Funds and (ii) the Funds, Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest in the ADS or Ordinary Shares received upon vesting of RSUs, Share Options, and ADS or Ordinary Shares received upon the exercise of Share Options (i.e. no direct pecuniary interest) issued as compensation for such Board service.

F8 · ownership.nature: The Adviser has voting and dispositive power over the Share Options, RSUs and any ADS or Ordinary Shares received as a result of the exercise of Share Options or vesting of RSUs.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
GrantEmployee Stock Option (right to buy) · Derivative 100,000 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0002015378-26-000002 · form4-01062026_080123.xml · derivative · entry 4

Hannay Michael Charles Ferguson · CIK 0002015378 · CHIEF PROD & SUPPLY CHAIN OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Ordinary Shares · 100,000 shares

Expires 2036-01-02

F6 · derivative.exercise_date: This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2027 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
SaleOrdinary Shares 2,827 $6.80 $19,223.60
Disclosure

SEC source: 0002015378-26-000002 · form4-01062026_080123.xml · nonDerivative · entry 2

Hannay Michael Charles Ferguson · CIK 0002015378 · CHIEF PROD & SUPPLY CHAIN OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,275

F3 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.62 to $7.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5).

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
GrantOrdinary Shares 50,000 $0.00 $0.00
Disclosure

SEC source: 0002015378-26-000002 · form4-01062026_080123.xml · nonDerivative · entry 1

Hannay Michael Charles Ferguson · CIK 0002015378 · CHIEF PROD & SUPPLY CHAIN OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,102

F1 · shares: Represents a restricted share unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 20:00 UTC GrantStock Option (right to buy) · Derivative 19,000 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0001783330-26-000002 · form4-01062026_080105.xml · derivative · entry 2

Bourque Janice · CIK 0001783330 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Ordinary Shares · 19,000 shares

Expires 2036-01-02

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 20:00 UTC GrantOrdinary Shares 9,500 $0.00 $0.00
Disclosure

SEC source: 0001783330-26-000002 · form4-01062026_080105.xml · nonDerivative · entry 1

Bourque Janice · CIK 0001783330 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,500

F1 · shares: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Lee KevinDirector · CHIEF EXECUTIVE OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 330,000 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0001776938-26-000002 · form4-01062026_080117.xml · derivative · entry 4

Lee Kevin · CIK 0001776938 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,000

Underlying: Ordinary Shares · 330,000 shares

Expires 2036-01-02

F6 · derivative.exercise_date: This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2027 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Lee KevinDirector · CHIEF EXECUTIVE OFFICER
SaleOrdinary Shares 10,325 $6.80 $70,210.00
Disclosure

SEC source: 0001776938-26-000002 · form4-01062026_080117.xml · nonDerivative · entry 2

Lee Kevin · CIK 0001776938 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 629,985

F3 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.62 to $7.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5).

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Lee KevinDirector · CHIEF EXECUTIVE OFFICER
GrantOrdinary Shares 165,000 $0.00 $0.00
Disclosure

SEC source: 0001776938-26-000002 · form4-01062026_080117.xml · nonDerivative · entry 1

Lee Kevin · CIK 0001776938 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 640,310

F1 · shares: Represents a restricted share unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantStock Option (right to buy) · Derivative 19,000 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0001667657-26-000002 · form4-01062026_080104.xml · derivative · entry 2

Gutierrez-Ramos Jose-Carlos · CIK 0001667657 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Ordinary Shares · 19,000 shares

Expires 2036-01-02

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantOrdinary Shares 9,500 $0.00 $0.00
Disclosure

SEC source: 0001667657-26-000002 · form4-01062026_080104.xml · nonDerivative · entry 1

Gutierrez-Ramos Jose-Carlos · CIK 0001667657 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,500

F1 · shares: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantStock Option (right to buy) · Derivative 6,065 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0001596492-26-000002 · form4-01062026_080107.xml · derivative · entry 2

Hoppenot Herve · CIK 0001596492 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,065

Underlying: Ordinary Shares · 6,065 shares

Expires 2036-01-02

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantOrdinary Shares 3,032 $0.00 $0.00
Disclosure

SEC source: 0001596492-26-000002 · form4-01062026_080107.xml · nonDerivative · entry 1

Hoppenot Herve · CIK 0001596492 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,532

F1 · shares: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantStock Option (right to buy) · Derivative 6,065 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0001741836-26-000002 · form4-01062026_080112.xml · derivative · entry 2

DANSEY ROGER D · CIK 0001741836 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,065

Underlying: Ordinary Shares · 6,065 shares

Expires 2036-01-02

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantOrdinary Shares 3,032 $0.00 $0.00
Disclosure

SEC source: 0001741836-26-000002 · form4-01062026_080112.xml · nonDerivative · entry 1

DANSEY ROGER D · CIK 0001741836 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,532

F1 · shares: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 75,000 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0001983944-26-000002 · form4-01062026_080126.xml · derivative · entry 4

Thompson Travis Alvin · CIK 0001983944 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Ordinary Shares · 75,000 shares

Expires 2036-01-02

F6 · derivative.exercise_date: This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2027 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
SaleOrdinary Shares 1,317 $6.80 $8,955.60
Disclosure

SEC source: 0001983944-26-000002 · form4-01062026_080126.xml · nonDerivative · entry 2

Thompson Travis Alvin · CIK 0001983944 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,380

F3 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.62 to $7.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5).

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
GrantOrdinary Shares 37,500 $0.00 $0.00
Disclosure

SEC source: 0001983944-26-000002 · form4-01062026_080126.xml · nonDerivative · entry 1

Thompson Travis Alvin · CIK 0001983944 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,697

F1 · shares: Represents a restricted share unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Skynner MichaelCHIEF TECHNOLOGY OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 100,000 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0001776582-26-000002 · form4-01062026_080124.xml · derivative · entry 4

Skynner Michael · CIK 0001776582 · CHIEF TECHNOLOGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Ordinary Shares · 100,000 shares

Expires 2036-01-02

F6 · derivative.exercise_date: This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2027 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Skynner MichaelCHIEF TECHNOLOGY OFFICER
SaleOrdinary Shares 3,045 $6.80 $20,706.00
Disclosure

SEC source: 0001776582-26-000002 · form4-01062026_080124.xml · nonDerivative · entry 2

Skynner Michael · CIK 0001776582 · CHIEF TECHNOLOGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,232

F3 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.62 to $7.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5).

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Skynner MichaelCHIEF TECHNOLOGY OFFICER
GrantOrdinary Shares 50,000 $0.00 $0.00
Disclosure

SEC source: 0001776582-26-000002 · form4-01062026_080124.xml · nonDerivative · entry 1

Skynner Michael · CIK 0001776582 · CHIEF TECHNOLOGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,277

F1 · shares: Represents a restricted share unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Milnes AlistairCHIEF OPERATING OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 100,000 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0001901321-26-000002 · form4-01062026_080121.xml · derivative · entry 4

Milnes Alistair · CIK 0001901321 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Ordinary Shares · 100,000 shares

Expires 2036-01-02

F6 · derivative.exercise_date: This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2027 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Milnes AlistairCHIEF OPERATING OFFICER
SaleOrdinary Shares 3,244 $6.80 $22,059.20
Disclosure

SEC source: 0001901321-26-000002 · form4-01062026_080121.xml · nonDerivative · entry 2

Milnes Alistair · CIK 0001901321 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,133

F3 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.62 to $7.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5).

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Milnes AlistairCHIEF OPERATING OFFICER
GrantOrdinary Shares 50,000 $0.00 $0.00
Disclosure

SEC source: 0001901321-26-000002 · form4-01062026_080121.xml · nonDerivative · entry 1

Milnes Alistair · CIK 0001901321 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,377

F1 · shares: Represents a restricted share unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Young AlethiaChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 100,000 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0001918147-26-000004 · form4-01062026_080119.xml · derivative · entry 5

Young Alethia · CIK 0001918147 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Ordinary Shares · 100,000 shares

Expires 2036-01-02

F8 · derivative.exercise_date: This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2027 and the remaining shares in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Young AlethiaChief Financial Officer
SaleOrdinary Shares 3,289 $6.80 $22,365.20
Disclosure

SEC source: 0001918147-26-000004 · form4-01062026_080119.xml · nonDerivative · entry 2

Young Alethia · CIK 0001918147 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,415

F3 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.62 to $7.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (5) and (7).

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC
Young AlethiaChief Financial Officer
GrantOrdinary Shares 50,000 $0.00 $0.00
Disclosure

SEC source: 0001918147-26-000004 · form4-01062026_080119.xml · nonDerivative · entry 1

Young Alethia · CIK 0001918147 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,704

F1 · shares: Represents a restricted share unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantStock Option (right to buy) · Derivative 19,000 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0001913319-26-000002 · form4-01062026_080116.xml · derivative · entry 2

Sands Stephen H. · CIK 0001913319 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Ordinary Shares · 19,000 shares

Expires 2036-01-02

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantOrdinary Shares 9,500 $0.00 $0.00
Disclosure

SEC source: 0001913319-26-000002 · form4-01062026_080116.xml · nonDerivative · entry 1

Sands Stephen H. · CIK 0001913319 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,893

F1 · shares: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantStock Option (right to buy) · Derivative 14,761 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0001867172-26-000002 · form4-01062026_080113.xml · derivative · entry 2

Riva Alessandro · CIK 0001867172 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,761

Underlying: Ordinary Shares · 14,761 shares

Expires 2036-01-02

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantOrdinary Shares 7,380 $0.00 $0.00
Disclosure

SEC source: 0001867172-26-000002 · form4-01062026_080113.xml · nonDerivative · entry 1

Riva Alessandro · CIK 0001867172 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,880

F1 · shares: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantStock Option (right to buy) · Derivative 19,000 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0001777021-26-000002 · form4-01062026_080109.xml · derivative · entry 2

Winter Gregory Paul · CIK 0001777021 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Ordinary Shares · 19,000 shares

Expires 2036-01-02

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantOrdinary Shares 9,500 $0.00 $0.00
Disclosure

SEC source: 0001777021-26-000002 · form4-01062026_080109.xml · nonDerivative · entry 1

Winter Gregory Paul · CIK 0001777021 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,427

F1 · shares: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantStock Option (right to buy) · Derivative 7,453 $0.00 Strike: $7.08 $0.00
Disclosure

SEC source: 0002079922-26-000002 · form4-01062026_080102.xml · derivative · entry 2

Swanton Robert Charles · CIK 0002079922 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,453

Underlying: Ordinary Shares · 7,453 shares

Expires 2036-01-02

F3 · derivative.exercise_date: This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 01:00 UTC GrantOrdinary Shares 3,726 $0.00 $0.00
Disclosure

SEC source: 0002079922-26-000002 · form4-01062026_080102.xml · nonDerivative · entry 1

Swanton Robert Charles · CIK 0002079922 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,213

F1 · shares: Represents a restricted share unit ("RSU") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026.

F2 · price: Each RSU represents a contingent right to receive one ordinary share.

Read SEC document
October 03, 2025 Filed Oct 6, 2025 20:45 UTC
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
SaleOrdinary Shares 250 $8.41 $2,102.50
Disclosure

SEC source: 0002015378-25-000003 · form4-10062025_041006.xml · nonDerivative · entry 2

Hannay Michael Charles Ferguson · CIK 0002015378 · CHIEF PROD & SUPPLY CHAIN OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,102

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.40 to $8.50 inclusive.

Read SEC document
October 03, 2025 Filed Oct 6, 2025 20:45 UTC
Lee KevinDirector · CHIEF EXECUTIVE OFFICER
SaleOrdinary Shares 3,231 $8.41 $27,172.71
Disclosure

SEC source: 0001776938-25-000004 · form4-10062025_041011.xml · nonDerivative · entry 2

Lee Kevin · CIK 0001776938 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 475,310

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.40 to $8.50 inclusive.

Read SEC document
October 03, 2025 Filed Oct 6, 2025 20:45 UTC
Skynner MichaelCHIEF TECHNOLOGY OFFICER
SaleOrdinary Shares 978 $8.41 $8,224.98
Disclosure

SEC source: 0001776582-25-000004 · form4-10062025_041010.xml · nonDerivative · entry 2

Skynner Michael · CIK 0001776582 · CHIEF TECHNOLOGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,277

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.40 to $8.50 inclusive.

Read SEC document
October 03, 2025 Filed Oct 6, 2025 20:45 UTC
Milnes AlistairCHIEF OPERATING OFFICER
SaleOrdinary Shares 978 $8.41 $8,224.98
Disclosure

SEC source: 0001901321-25-000003 · form4-10062025_041008.xml · nonDerivative · entry 2

Milnes Alistair · CIK 0001901321 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,377

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.40 to $8.50 inclusive.

Read SEC document
October 03, 2025 Filed Oct 6, 2025 20:45 UTC
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
SaleOrdinary Shares 103 $8.41 $866.23
Disclosure

SEC source: 0001983944-25-000003 · form4-10062025_041003.xml · nonDerivative · entry 2

Thompson Travis Alvin · CIK 0001983944 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,197

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.40 to $8.50 inclusive.

Read SEC document
October 02, 2025 Filed Oct 6, 2025 20:45 UTC
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
SaleOrdinary Shares 473 $8.40 $3,973.20
Disclosure

SEC source: 0002015378-25-000003 · form4-10062025_041006.xml · nonDerivative · entry 1

Hannay Michael Charles Ferguson · CIK 0002015378 · CHIEF PROD & SUPPLY CHAIN OFF

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,352

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.37 to $8.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
October 02, 2025 Filed Oct 6, 2025 20:45 UTC
Lee KevinDirector · CHIEF EXECUTIVE OFFICER
SaleOrdinary Shares 2,263 $8.40 $19,009.20
Disclosure

SEC source: 0001776938-25-000004 · form4-10062025_041011.xml · nonDerivative · entry 1

Lee Kevin · CIK 0001776938 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 478,541

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.31 to $8.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
October 02, 2025 Filed Oct 6, 2025 20:45 UTC
Skynner MichaelCHIEF TECHNOLOGY OFFICER
SaleOrdinary Shares 824 $8.40 $6,921.60
Disclosure

SEC source: 0001776582-25-000004 · form4-10062025_041010.xml · nonDerivative · entry 1

Skynner Michael · CIK 0001776582 · CHIEF TECHNOLOGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,255

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.31 to $8.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
October 02, 2025 Filed Oct 6, 2025 20:45 UTC
Milnes AlistairCHIEF OPERATING OFFICER
SaleOrdinary Shares 1,147 $8.40 $9,634.80
Disclosure

SEC source: 0001901321-25-000003 · form4-10062025_041008.xml · nonDerivative · entry 1

Milnes Alistair · CIK 0001901321 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,355

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.31 to $8.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
October 02, 2025 Filed Oct 6, 2025 20:45 UTC
Young AlethiaChief Financial Officer
SaleOrdinary Shares 265 $8.61 $2,280.33
Disclosure

SEC source: 0001918147-25-000004 · form4-10062025_041004.xml · nonDerivative · entry 2

Young Alethia · CIK 0001918147 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,704

F3 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on April 3, 2025.

Read SEC document
October 02, 2025 Filed Oct 6, 2025 20:45 UTC
Young AlethiaChief Financial Officer
SaleOrdinary Shares 217 $8.40 $1,822.80
Disclosure

SEC source: 0001918147-25-000004 · form4-10062025_041004.xml · nonDerivative · entry 1

Young Alethia · CIK 0001918147 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,969

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.37 to $8.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 02, 2025 Filed Oct 6, 2025 20:45 UTC
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
SaleOrdinary Shares 221 $8.40 $1,856.40
Disclosure

SEC source: 0001983944-25-000003 · form4-10062025_041003.xml · nonDerivative · entry 1

Thompson Travis Alvin · CIK 0001983944 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,300

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of restricted stock units. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.37 to $8.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
October 02, 2025 Filed Oct 6, 2025 20:45 UTC SaleOrdinary Shares 102 $8.55 $872.10
Disclosure

SEC source: 0002079922-25-000002 · form4-10062025_041001.xml · nonDerivative · entry 1

Swanton Robert Charles · CIK 0002079922 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,487

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on October 14, 2024.

Read SEC document
September 08, 2025 Filed Sep 10, 2025 20:53 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $7.16 $0.00
Disclosure

SEC source: 0001415889-25-024100 · form4-09102025_080931.xml · derivative · entry 2

Hoppenot Herve · CIK 0001596492 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Ordinary Shares · 25,000 shares

Expires 2035-09-08

F3 · derivative.exercise_date: This option will vest in three equal installments on each of September 8, 2026, September 8, 2027 and September 8, 2028.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.